×
×
homepage logo
LOGIN
SUBSCRIBE

Business & Tech

Moderna surprises the Street by predicting a bigger-than-expected sales drop

Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. Analysts expect, on ...